Schedule 13G ownership disclosure

TITAN PHARMACEUTICALS INC D COM

Security class unavailable · CUSIP: 888314507

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,922,395
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-20-000479
Form type
SC 13G/A
Filer
Empery Asset Management, LP
CIK
CIK 1469336
Filed
Jan 27, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub